acinetobacter


Also found in: Medical, Encyclopedia, Wikipedia.

acinetobacter

(ˈæsɪnɪtʊˌbæktə)
n
(Microbiology) a bacterium that causes infections such as pneumonia, particularly in people who have a compromised immune system
[C20: from Greek acetinae immovable + bacter(ium)]
References in periodicals archive ?
During the conference, Ruben Tommasi, PhD, Chief Scientific Officer at Entasis, provided an overview of the Company's pipeline, underscoring the broad antibacterial activity of sulbactam-durlobactam against Acinetobacter through inhibition of Class A, C and D beta-lactamases and the potential utility of zoliflodacin as a novel single-dose oral treatment for gonorrhea.
Acinetobacter (A.) baumannii is a glucose non-fermentative gram-negative coccobacillus, considered a relevant nosocomial pathogen occurring particularly in intensive care units (ICUs), as well as in burn therapy units (1).
The contract has been signed to develop bacteriophage lysins for the treatment of multidrug resistant Acinetobacter infections, a frequent cause of hospital-acquired pneumonia and life-threatening blood or wound infections.
Acinetobacter baumannii, a major source of nosocomial infections, is no exception, and 2 MLST schemes (Oxford and Pasteur) have been established for this species (3,4).
Acinetobacter baumannii is an encapsulated, catalase-positive, non-motile, Gram-negative coccobacilli bacterium (1).
Specimen wise distribution of the identified blood culture isolates were found to be Citrobacter koseri (5), Staphylococcus aureus (3), Pseudomonas aeruginosa (3), and isolate of Staphylococcus saprophyticus (1), coagulase negative staphylococcus (1), Acinetobacter baumannii (1), Escherichia coli(1), Klebsiella pneumoniae (1), Klebsiella oxytoca (1), Enterobacter aerogenes (1), and Citrobacter freundii (1) respectively.
The New Jersey Department of Health learned late Monday that two premature infants with confirmed cases of Acinetobacter baumannii died last week in the neonatal intensive care unit at University Hospital in Newark.The New Jersey Department of Health learned late Monday that two premature infants with confirmed cases of Acinetobacter baumannii died last week in the neonatal intensive care unit at University Hospital in Newark.
Acinetobacter baumannii is an aerobic, non-motile gram negative bacillus and an important cause of hospital acquired infections.
Acinetobacter baumanii being the predominant pathogen isolated from 32 (54.2%) patients followed by MRSA 11 (18.6%), Klebsiella pneumoniae 9 (15.2%), Pseudomonas aeruginosa 5 (8.47%) and Stenotrophomonas maltophila from 2 (3.38%) patients.
Acinetobacter is a gram-negative, nonmotile, obligate aerobic, oxidasenegative, and non-fermenting rod belonging to the Moraxellaceae family.
Acinetobacter baumannii (ACB) has been considered a worrisome bacterial agent associated with hospital-acquired infections (HAI), mainly in developing countries.